Back
Day Range
$3.04
$3.13
52-Week Range
$1.67
$4.11
Volume
1,462,517
50D / 200D Avg
$3.42
/
$3.02
Prev Close
$3.07
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -6.5 | 0.3 |
| P/B | 4.0 | 2.9 |
| ROE % | -48.6 | 3.7 |
| Net Margin % | -70.4 | 3.8 |
| Rev Growth 5Y % | -30.6 | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$4.50
+46.1%
Forward EPS
-$0.18
Est. Revenue
200 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$0.15
-$0.15 – -$0.15
|
260 M | 1 |
| FY2029 |
-$0.17
-$0.17 – -$0.16
|
250 M | 1 |
| FY2028 |
-$0.12
-$0.15 – -$0.10
|
240 M | 2 |
Key Takeaways
Revenue declined -30.57% annually over 5 years
Debt/Equity of 0.17 — conservative balance sheet
Negative free cash flow of -70.72M
PEG of 0.27 suggests growth is underpriced
Capital efficient — spends only 7.08% of revenue on capex
Growth
Revenue Growth (5Y)
-30.57%
Revenue (1Y)-28.34%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-48.64%
ROIC-2.04%
Net Margin-70.41%
Op. Margin-3.63%
Safety
Debt / Equity
0.17
Current Ratio6.60
Interest Coverage-0.25
Valuation
P/E Ratio
-6.47
P/B Ratio3.98
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -28.34% | Revenue Growth (3Y) | -19.82% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -30.57% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 185.74M | Net Income (TTM) | -130.77M |
| ROE | -48.64% | ROA | -16.97% |
| Gross Margin | 17.98% | Operating Margin | -3.63% |
| Net Margin | -70.41% | Free Cash Flow (TTM) | -70.72M |
| ROIC | -2.04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.17 | Current Ratio | 6.60 |
| Interest Coverage | -0.25 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -6.47 | P/B Ratio | 3.98 |
| P/S Ratio | 4.56 | PEG Ratio | 0.27 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 846.23M | Enterprise Value | 664.92M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 185.74M | 259.19M | 288.95M | 883.00M | 799.24M |
| Net Income | -130.77M | -144.85M | -119.03M | 220.21M | 182.04M |
| EPS (Diluted) | -0.91 | -1.05 | -0.90 | 1.67 | 1.56 |
| Gross Profit | 33.39M | 108.31M | 140.20M | 714.04M | 658.68M |
| Operating Income | -6.74M | -235.62M | -31.65M | 574.22M | 554.65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 770.58M | 1.01B | 1.49B | 2.28B | 1.92B |
| Total Liabilities | 397.87M | 431.04M | 697.57M | 1.38B | 1.37B |
| Shareholders' Equity | 212.38M | 325.29M | 416.75M | 545.22M | 315.50M |
| Total Debt | 35.58M | 376.69M | 610.97M | 585.26M | 575.22M |
| Cash & Equivalents | 216.89M | 322.40M | 574.96M | 632.14M | 551.27M |
| Current Assets | 296.25M | 429.15M | 699.91M | 847.90M | 740.04M |
| Current Liabilities | 44.92M | 56.97M | 87.47M | 110.14M | 93.78M |